Browsing Tag
Amylyx Pharmaceuticals Inc.
1 post
Amylyx Phase 3 win sends AMLX soaring as avexitide cuts hypoglycemia events 55%
Amylyx Pharmaceuticals’ avexitide reduced clinically significant hypoglycemic events by 55% in the pivotal LUCIDITY trial, putting the company on track for an FDA filing by year-end and triggering a sharp re-rating in AMLX shares.